1. Home
  2. GS vs NVS Comparison

GS vs NVS Comparison

Compare GS & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Goldman Sachs Group Inc. (The)

GS

Goldman Sachs Group Inc. (The)

HOLD

Current Price

$864.20

Market Cap

288.5B

Sector

Finance

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$151.12

Market Cap

286.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GS
NVS
Founded
1869
1895
Country
United States
Switzerland
Employees
N/A
75267
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.5B
286.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GS
NVS
Price
$864.20
$151.12
Analyst Decision
Hold
Hold
Analyst Count
15
5
Target Price
$872.60
$144.00
AVG Volume (30 Days)
1.9M
1.8M
Earning Date
04-13-2026
04-28-2026
Dividend Yield
2.08%
2.02%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.36
$2.34
Revenue Next Year
$4.92
$5.14
P/E Ratio
$18.19
$23.13
Revenue Growth
N/A
N/A
52 Week Low
$447.11
$97.72
52 Week High
$984.70
$170.46

Technical Indicators

Market Signals
Indicator
GS
NVS
Relative Strength Index (RSI) 56.24 45.00
Support Level $701.17 $145.30
Resistance Level $969.82 $158.80
Average True Range (ATR) 23.00 2.19
MACD 9.52 0.34
Stochastic Oscillator 90.83 54.57

Price Performance

Historical Comparison
GS
NVS

About GS Goldman Sachs Group Inc. (The)

Goldman Sachs is a storied financial institution, founded in 1869 and best known for its role as a leading global investment bank. The firm has a sprawling reach across global financial centers and has been the leading provider of global merger and acquisition advisory services, by revenue, for the past 20 years. Since the global financial crisis, Goldman has expanded its offerings into more stable fee-based businesses like asset and wealth management, which comprised roughly 30% of post-provision revenue at the end of 2025. The bank holding company generates revenue from investment banking, global market making and trading, lending, asset management, wealth management, and a small and declining portfolio of consumer credit card loans.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: